Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension. (Q50656351)
Jump to navigation
Jump to search
scientific article published on 18 April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension. |
scientific article published on 18 April 2017 |
Statements
Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension. (English)
1 reference
Yasuki Kihara
1 reference
Nobuhiro Tanabe
1 reference
Satoshi Ikeda
1 reference
Nobuhiro Tahara
1 reference
Keiichi Fukuda
1 reference
Masaru Hatano
1 reference
Hiroshi Ito
1 reference
Tomotaka Nakayama
1 reference
Toshihisa Anzai
1 reference
Akiyoshi Hashimoto
1 reference
Teruo Inoue
1 reference
Kouji Kajinami
1 reference
Hideyuki Kinoshita
1 reference
Koichiro Kuwahara
1 reference
Toyoaki Murohara
1 reference
Osamu Okazaki
1 reference
Satoshi Sakai
1 reference
Toru Satoh
1 reference
Yutaka Takeda
1 reference
Yasuchika Takeishi
1 reference
Mitsugu Taniguchi
1 reference
Hiroshi Watanabe
1 reference
Takeshi Yamamoto
1 reference
Keiko Yamauchi-Takihara
1 reference
Koichiro Yoshioka
1 reference
Shigetake Sasayama
1 reference
18 April 2017
1 reference
81
1 reference
9
1 reference
1360-1367
1 reference